Vascular alterations among young adults with SARS-CoV-2.
Adolescent
Angiotensin-Converting Enzyme 2
/ metabolism
Area Under Curve
Blood Vessels
/ metabolism
Brachial Artery
/ diagnostic imaging
COVID-19
/ diagnostic imaging
Carotid-Femoral Pulse Wave Velocity
Case-Control Studies
Cross-Sectional Studies
Female
Femoral Artery
/ physiopathology
Humans
Hyperemia
/ diagnostic imaging
Male
SARS-CoV-2
Severity of Illness Index
Ultrasonography, Doppler
Vascular Stiffness
/ physiology
Vasodilation
/ physiology
Young Adult
COVID-19
SARS-CoV-2
flow-mediated dilation
passive limb movement
pulse wave velocity
Journal
American journal of physiology. Heart and circulatory physiology
ISSN: 1522-1539
Titre abrégé: Am J Physiol Heart Circ Physiol
Pays: United States
ID NLM: 100901228
Informations de publication
Date de publication:
01 01 2021
01 01 2021
Historique:
pubmed:
12
12
2020
medline:
23
1
2021
entrez:
11
12
2020
Statut:
ppublish
Résumé
While SARS-CoV-2 primarily affects the lungs, the virus may be inflicting detriments to the cardiovascular system, both directly through angiotensin-converting enzyme 2 receptor and initiating systemic inflammation. Persistent systemic inflammation may be provoking vascular dysfunction, an early indication of cardiovascular disease risk. To establish the potential effects of SARS-CoV-2 on the systemic vasculature in the arms and legs, we performed a cross-sectional analysis of young healthy adults (control: 5 M/15 F, 23.0 ± 1.3 y, 167 ± 9 cm, 63.0 ± 7.4 kg) and young adults who, 3-4 wk prior to testing, had tested positive for SARS-CoV-2 (SARS-CoV-2: 4 M/7 F, 20.2 ± 1.1 y, 172 ± 12 cm, 69.5 ± 12.4 kg) (means ± SD). Using Doppler ultrasound, brachial artery flow-mediated dilation (FMD) in the arm and single passive limb movement (sPLM) in the leg were assessed as markers of vascular function. Carotid-femoral pulse wave velocity (PWVcf) was asvsessed as a marker of arterial stiffness. FMD was lower in the SARS-CoV-2 group (2.71 ± 1.21%) compared with the control group (8.81 ± 2.96%) (
Identifiants
pubmed: 33306450
doi: 10.1152/ajpheart.00897.2020
pmc: PMC8083172
doi:
Substances chimiques
ACE2 protein, human
EC 3.4.17.23
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
H404-H410Subventions
Organisme : Appalachian State University
ID : COVID-19 Cluster Award
Pays : International
Commentaires et corrections
Type : CommentIn
Références
Circ Res. 2011 May 27;108(11):1358-66
pubmed: 21493895
J Appl Physiol (1985). 1996 Oct;81(4):1807-14
pubmed: 8904603
Hypertension. 2010 May;55(5):1075-85
pubmed: 20351340
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Cardiovasc Res. 2020 Dec 1;116(14):2177-2184
pubmed: 32750108
J Physiol. 2012 Mar 15;590(6):1413-25
pubmed: 22310310
Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2113-9
pubmed: 17717291
Circulation. 1995 Mar 1;91(5):1314-9
pubmed: 7867167
Circ Res. 2013 Sep 27;113(8):1023-32
pubmed: 23940309
J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27
pubmed: 20338492
Front Immunol. 2014 May 27;5:253
pubmed: 24904596
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Circulation. 2005 May 24;111(20):2605-10
pubmed: 15897343
Circulation. 2020 May 19;141(20):1648-1655
pubmed: 32200663
Cytokine Growth Factor Rev. 2020 Jun;53:25-32
pubmed: 32446778
Int J Cardiovasc Imaging. 2010 Aug;26(6):631-40
pubmed: 20339920
Catheter Cardiovasc Interv. 2020 Aug;96(2):336-345
pubmed: 32311816
Hypertension. 2019 Jul;74(1):208-215
pubmed: 31055952
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Circ Res. 1998 Nov 2;83(9):960-5
pubmed: 9797346
J Vasc Surg. 1990 May;11(5):688-94
pubmed: 2186185
Lancet. 1992 Nov 7;340(8828):1111-5
pubmed: 1359209
Scand J Immunol. 2020 Aug;92(2):e12895
pubmed: 32445403
Circulation. 2009 Aug 11;120(6):502-9
pubmed: 19635967
Trends Cardiovasc Med. 2021 Jan;31(1):1-5
pubmed: 33068723
Cell. 2020 May 14;181(4):905-913.e7
pubmed: 32333836
Eur Heart J. 2006 Nov;27(21):2588-605
pubmed: 17000623
J Appl Physiol (1985). 2017 Dec 1;123(6):1708-1720
pubmed: 28883048
N Engl J Med. 2020 May 14;382(20):e60
pubmed: 32343504